Roche does $400M upfront, $15B deal with China's Hansoh

Part of story

Roche partners with Hansoh Pharma in deal worth over $15 billion

Roche has entered a partnership and licensing deal with China's Hansoh Pharmaceutical worth potentially more than $15 billion, covering a portfolio of antibody-drug conjugates across multiple cancer types.

Oct 19, 20263 sourcesCancer treatment breakthroughs

Roche partners with Hansoh Pharma in deal worth over $15 billion

Other sources for this story

The Wall Street Journal

Roche Partners With China’s Hansoh in Deal That Could Top $15 Billion

Reuters

Roche does $400M upfront, $15B deal with China's Hansoh

Part of story

Roche partners with Hansoh Pharma in deal worth over $15 billion

Other sources for this story

Roche Partners With China’s Hansoh in Deal That Could Top $15 Billion

China's Hansoh Pharma strikes drug deal with Roche worth over $15 billion | Reuters

Roche does $400M upfront, $15B deal with China's Hansoh

Part of story

Roche partners with Hansoh Pharma in deal worth over $15 billion

Other sources for this story

Roche Partners With China’s Hansoh in Deal That Could Top $15 Billion

China's Hansoh Pharma strikes drug deal with Roche worth over $15 billion | Reuters